SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq:SOPH) announced leadership will present at TD Cowen's 46th Annual Health Care Conference in Boston.

Jurgi Camblong, CEO and co-founder, and Ross Muken, President, will participate in a fireside chat on March 4, 2026 at 10:30 am EST / 4:30 pm CET. According to the company, a live audio webcast will be available and a replay will be accessible for 90 days after the event.

News Market Reaction – SOPH

+1.32%

+1.32% Session close to close

In the Feb 25 session, SOPH gained 1.32%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights SOPHiA GENETICS’ participation in a major healthcare conference, offeri...

Analysis

This announcement highlights SOPHiA GENETICS’ participation in a major healthcare conference, offering additional visibility as management discusses strategy on March 4, 2026. Set against a backdrop of recent U.S. expansion deals, preliminary 2025 results, and an MD Anderson collaboration, it continues a cadence of investor-facing updates. Investors may watch upcoming reported results and execution on partnerships more closely than this forum appearance itself when assessing the company’s trajectory.

Key Figures

Conference date: March 4, 2026 Session time (EST): 10:30 am EST Session time (CET): 4:30 pm CET +1 more

4 metrics

Conference date March 4, 2026 TD Cowen Health Care Conference fireside chat date

Session time (EST) 10:30 am EST Scheduled time for conference fireside chat

Session time (CET) 4:30 pm CET Corresponding European time for fireside chat

Webcast replay window 90 days Duration webcast replay remains available after event

Historical Context

5 past events · Latest: Feb 17 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 17	Earnings date notice	Neutral	+0.2%	Announcement of upcoming Q4 and full-year 2025 results call date.
Feb 10	US expansion deal	Positive	-1.4%	Signing of two major U.S. integrated health systems to SOPHiA network.
Jan 15	Innovation awards	Positive	+0.2%	Recognition via multiple innovation awards for product advances.
Jan 12	Prelim results & guidance	Neutral	-2.6%	Preliminary 2025 results, 2026 guidance, and executive transition plan.
Jan 07	Oncology collaboration	Positive	+4.2%	Strategic collaboration with MD Anderson on AI-based precision oncology.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent SOPH headlines show mixed price reactions, with strategic collaborations and operational updates sometimes aligning with gains, but commercial and financial news not consistently bid up.

Recent Company History

Over the past few months, SOPHiA GENETICS has reported several notable developments. On Jan 7, a collaboration with MD Anderson around AI-driven precision oncology coincided with a 4.17% gain. Preliminary FY 2025 results and 2026 guidance on Jan 12 saw the stock down 2.65%. A major U.S. expansion deal on Feb 10 was followed by a 1.44% decline, while an earnings-date notice on Feb 17 was essentially flat. Today’s conference appearance fits into this cadence of frequent investor and commercial updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON and ROLLE, Switzerland, Feb. 25, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced that leadership will present at TD Cowen's 46^th Annual Health Care Conference in Boston. Jurgi Camblong, Chief Executive Officer and co-founder of SOPHiA GENETICS, and Ross Muken, President of SOPHiA GENETICS, will participate in a fireside chat on Wednesday, March 4, 2026, at 10:30 am EST / 4:30 pm CET.

A live audio webcast of the fireside chat will be available here. Additionally, a replay of the webcast will be available for 90 days following the event.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM^TM, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-present-at-the-46th-annual-td-cowen-health-care-conference-302696166.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) present at the TD Cowen Health Care Conference?

SOPHiA GENETICS will present on Wednesday, March 4, 2026 at 10:30 am EST during a fireside chat. According to SOPHiA GENETICS, CEO Jurgi Camblong and President Ross Muken will participate and the session occurs at TD Cowen's 46th Annual Health Care Conference.

Who from SOPHiA GENETICS (SOPH) will speak at the March 4, 2026 fireside chat?

Jurgi Camblong, CEO and co-founder, and Ross Muken, President, will speak in the fireside chat. According to SOPHiA GENETICS, both executives will present perspectives on the company's strategy during the TD Cowen conference session.

How can investors listen to SOPHiA GENETICS (SOPH) at the TD Cowen conference on March 4, 2026?

Investors can listen via a live audio webcast of the fireside chat on March 4, 2026 at 10:30 am EST. According to SOPHiA GENETICS, a replay will also be available for 90 days after the event.

Will a replay of the SOPHiA GENETICS (SOPH) TD Cowen presentation be available after March 4, 2026?

Yes. A replay of the audio webcast will be available for 90 days following the March 4, 2026 presentation. According to SOPHiA GENETICS, the replay period applies to the fireside chat featuring its leadership team.

What topics will SOPHiA GENETICS (SOPH) leadership likely cover at the TD Cowen Health Care Conference?

The company will present strategic and business updates during a fireside chat on March 4, 2026 with its CEO and President. According to SOPHiA GENETICS, the session will reflect leadership perspectives on the company's AI-driven precision medicine work and outlook.